What does APOTHEEK DE STERRE do?

APOTHEEK DE STERRE is a pharmacy in Gent. Private Limited, started on 5 September 1996, 1 establishment.

What is the address of APOTHEEK DE STERRE?

The registered office of APOTHEEK DE STERRE is located at Voskenslaan 399, 9000 Gent.

Is APOTHEEK DE STERRE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK DE STERRE is active, legal situation “Normale toestand”, started on 5 September 1996.

Is APOTHEEK DE STERRE registered on Peppol?

Yes, APOTHEEK DE STERRE is registered on the Peppol network with ID 0208:0458740219.

What is the enterprise number of APOTHEEK DE STERRE?

The enterprise number of APOTHEEK DE STERRE is BE0458740219.

When was APOTHEEK DE STERRE founded?

APOTHEEK DE STERRE was founded on 5 September 1996.

Who are the directors of APOTHEEK DE STERRE?

According to the 2025 annual accounts, the directors of APOTHEEK DE STERRE are: PHARMA POPERINGE BV.

Is APOTHEEK DE STERRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 September 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK DE STERRE make in 2025?

APOTHEEK DE STERRE posted a profit after taxes of € 105,021 in financial year 2025.

What is the revenue of APOTHEEK DE STERRE?

As a small company, APOTHEEK DE STERRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 128,250.

How many employees does APOTHEEK DE STERRE have?

According to the 2025 annual accounts, APOTHEEK DE STERRE has 0 full-time equivalents (FTE).

APOTHEEK DE STERRE (Private Limited) - Gent

Dossier APOTHEEK DE STERRE, printed on 30 October 2026 from databakkes.be/en/0458740219/apotheek-de-sterre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK DE STERRE from Gent, company number BE0458740219, closed financial year 2025 with a result of € 105,021 after tax. For that financial year APOTHEEK DE STERRE recorded a gross margin of € 128,250 and equity of € 154,111. Compared with financial year 2024, the result moved from € 113,526 to € 105,021. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 154,111

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 105,021

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 206,478

▲ 83% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 198,558 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 3,942

▲ 61% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 512,686

▲ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,310

▲ € 5,526 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,539 Gross margin 2022: € 134,539 First fiscal year in the series	€ 158,263 Gross margin 2023: € 158,263 ▲ 18% vs 2022 (€ 134,539) Favourable step	€ 138,545 Gross margin 2024: € 138,545 ▼ 12% vs 2023 (€ 158,263) Unfavourable step	€ 128,250 Gross margin 2025: € 128,250 ▼ 7% vs 2024 (€ 138,545) Unfavourable step	▼ 7%
Profit after taxes	€ 106,705 Profit after taxes 2022: € 106,705 First fiscal year in the series	€ 133,346 Profit after taxes 2023: € 133,346 ▲ 25% vs 2022 (€ 106,705) Favourable step	€ 113,526 Profit after taxes 2024: € 113,526 ▼ 15% vs 2023 (€ 133,346) Unfavourable step	€ 105,021 Profit after taxes 2025: € 105,021 ▼ 7% vs 2024 (€ 113,526) Unfavourable step	▼ 7%
Equity	€ 541,014 Equity 2022: € 541,014 First fiscal year in the series	€ 419,237 Equity 2023: € 419,237 ▼ 23% vs 2022 (€ 541,014) Unfavourable step	€ 247,649 Equity 2024: € 247,649 ▼ 41% vs 2023 (€ 419,237) Unfavourable step	€ 154,111 Equity 2025: € 154,111 ▼ 38% vs 2024 (€ 247,649) Unfavourable step	▼ 38%
Total debts	€ 453,756 Total debts 2022: € 453,756 First fiscal year in the series	€ 219,757 Total debts 2023: € 219,757 ▼ 52% vs 2022 (€ 453,756) Favourable step	€ 470,225 Total debts 2024: € 470,225 ▲ 114% vs 2023 (€ 219,757) Unfavourable step	€ 709,771 Total debts 2025: € 709,771 ▲ 51% vs 2024 (€ 470,225) Unfavourable step	▲ 51%
Cash	€ 411,821 Cash 2022: € 411,821 First fiscal year in the series	€ 113,789 Cash 2023: € 113,789 ▼ 72% vs 2022 (€ 411,821) Unfavourable step	€ 112,578 Cash 2024: € 112,578 ▼ 1% vs 2023 (€ 113,789) Unfavourable step	€ 206,478 Cash 2025: € 206,478 ▲ 83% vs 2024 (€ 112,578) Favourable step	▲ 83%
Land & buildings	€ 131,527 Land & buildings 2022: € 131,527 First fiscal year in the series	€ 117,348 Land & buildings 2023: € 117,348 ▼ 11% vs 2022 (€ 131,527) Unchanged	€ 104,706 Land & buildings 2024: € 104,706 ▼ 11% vs 2023 (€ 117,348) Unchanged	€ 92,687 Land & buildings 2025: € 92,687 ▼ 11% vs 2024 (€ 104,706) Unchanged	▼ 11%
Retained profit	€ 522,414 Retained profit 2022: € 522,414 First fiscal year in the series	€ 400,637 Retained profit 2023: € 400,637 ▼ 23% vs 2022 (€ 522,414) Unfavourable step	€ 229,049 Retained profit 2024: € 229,049 ▼ 43% vs 2023 (€ 400,637) Unfavourable step	€ 135,511 Retained profit 2025: € 135,511 ▼ 41% vs 2024 (€ 229,049) Unfavourable step	▼ 41%
Dividend	€ 221,852 Dividend 2022: € 221,852 First fiscal year in the series	€ 255,123 Dividend 2023: € 255,123 ▲ 15% vs 2022 (€ 221,852) Unchanged	€ 285,115 Dividend 2024: € 285,115 ▲ 12% vs 2023 (€ 255,123) Unchanged	€ 198,558 Dividend 2025: € 198,558 ▼ 30% vs 2024 (€ 285,115) Unchanged	▼ 30%
Balance sheet total	€ 994,770 Balance sheet total 2022: € 994,770 First fiscal year in the series	€ 638,994 Balance sheet total 2023: € 638,994 ▼ 36% vs 2022 (€ 994,770) Unchanged	€ 717,874 Balance sheet total 2024: € 717,874 ▲ 12% vs 2023 (€ 638,994) Unchanged	€ 863,882 Balance sheet total 2025: € 863,882 ▲ 20% vs 2024 (€ 717,874) Unchanged	▲ 20%

Key figures of APOTHEEK DE STERRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK DE STERRE?

What happened at APOTHEEK DE STERRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 105,021 (▼ 7% vs 2024). Source: NBB ↗
2020 PHARMA POPERINGE BV became a director. NBB
Sep 25, 1996 New establishment in Gent. KBO
Sep 5, 1996 Start of the company according to the CBE. KBO

In short

From € 106,705 profit in 2022 to € 105,021 profit in 2025.

Paid € 11,743 in corporate taxes since 2022.

Best year ever: 2023, with € 133,346 profit.

Paid out € 960,648 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PHARMA POPERINGE BV

APOTHEEK DE STERRE

Behind APOTHEEK DE STERRE is PHARMA POPERINGE BV.

Directors

According to the 2025 annual accounts

PHARMA POPERINGE BV

Director · represented by Haghedooren Yves

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Voskenslaan 399

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Pharma Poperinge same network

€ 298,760 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0458.740.219

VAT number

BE 0458.740.219

Registered office

Voskenslaan 399, 9000 Gent

Names & denominations

APOTHEEK DE STERRE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 September 1996

Peppol

Active · Active since 4 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Groothandel in farmaceutische en medische artikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Groothandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DE STERRE

Financials

What happened to APOTHEEK DE STERRE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions